Back to Agenda
What is the Value of Reference Agency Assessment Reports in Enabling Reliance and What do Relying Agencies Require?
Session Chair(s)
Magda Bujar, PhD, MSc
Senior Manager, Regulatory Programme and Strategic Partnerships
Centre for Innovation in Regulatory Science (CIRS), United Kingdom
Challenges remain in the implementation of reliance. This session will bring together stakeholders to discuss the utilisation of assessment reports, and recommend ways to ensure effective and efficient systems in the future.
Learning Objective : Recognize the value of assessment reports in enabling reliance; Describe current use of public and non-public information for enabling regulatory reviews; Discuss how documentation and information sharing could improve to ensure reliance becomes successful.
Speaker(s)
Reference Agency Viewpoint
Emer Cooke, MBA, MSc
European Medicines Agency, Netherlands
Chair, ICMRA; Executive Director
Relying Agency Viewpoint
Patricia Oliveira Pereira Tagliari, LLM, MPH
ANVISA, Brazil
Associate Director of the Second Directorate
Industry Viewpoint
Susanne Ausborn, PhD
Roche, Switzerland
Global Head International Regulatory Policy
WHO Update
Samvel Azatyan, MD, PhD
World Health Organization (WHO), Switzerland
Team Lead, Regulatory Convergence and Networks (RCN/REG)
Have an account?